Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.
Depression and Anxiety August 1, 2020 Reilly R Kayser, Margaret Haney, Marissa Raskin et al.
Preclinical data implicate the endocannabinoid system in the pathology underlying obsessive-compulsive disorder (OCD), while survey data have linked OCD symptoms to increased cannabis use. Cannabis products are increasingly marketed as treatments for anxiety and other OCD-related symptoms. Yet, few studies have tested the acute effects of cannabis on psychiatric symptoms in humans. We recruited...